Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA; F.I. Proctor Foundation, University of California, San Francisco, San Francisco, California, USA.
Department of Ophthalmology, University of California, San Francisco, San Francisco, California, USA; Carl Zeiss, Meditec, Dublin, California, USA; Optical Express, Glasgow, United Kingdom.
Am J Ophthalmol. 2019 Dec;208:406-414. doi: 10.1016/j.ajo.2019.08.025. Epub 2019 Sep 4.
To evaluate the incidence of adverse events (AEs) in patients who underwent refractive lens exchange.
Retrospective case series.
Setting: Private refractive surgery clinics. Patients/Study Population: Patients who underwent refractive lens exchange between July 1, 2014, and June 30, 2016. Intervention/Observation Procedures: All AEs recorded in the electronic medical record were extracted and retrospectively reviewed. The total incidence of AEs and serious AEs was calculated. Loss of 2 or more lines of corrected distance visual acuity (CDVA) was calculated for the entire cohort of patients that attended a minimum of 3 months follow-up.
AEs.
The total number of patients included was 10,206 (18,689 eyes). A multifocal intraocular lens (IOL) was implanted in 84.3% of eyes; 15.7% of eyes received a monofocal IOL. A total of 1164 AEs were recorded (1112 eyes of 1039 patients, incidence 6.0% of eyes, 1:17 eyes). The most common AE was posterior capsular opacification (PCO; 748 eyes, incidence 4.0%). Of all AEs, 171 events (occurring in 165 eyes of 151 patients, incidence 0.9%, 1:113 eyes) were classified as serious, potentially sight threatening. Loss of 2 or more lines of CDVA was 0.56% when excluding eyes where the loss of CDVA was due to PCO; the majority of these were due to macular causes.
The incidence of sight-threatening AEs and significant loss of CDVA in elective refractive lens exchange surgery was low. Other than PCO, postoperative macular issues were the most common cause of vision loss in this cohort.
评估接受屈光性晶状体置换术患者的不良事件(AE)发生率。
回顾性病例系列。
设置:私人屈光手术诊所。患者/研究人群:2014 年 7 月 1 日至 2016 年 6 月 30 日期间接受屈光性晶状体置换术的患者。干预/观察程序:从电子病历中提取并回顾性审查所有记录的 AE。计算 AE 和严重 AE 的总发生率。对至少随访 3 个月的所有患者计算视力矫正后 2 行以上(CDVA)丢失的发生率。
AE。
共纳入 10206 例患者(18689 只眼)。84.3%的眼植入了多焦点人工晶状体(IOL);15.7%的眼植入了单焦点 IOL。共记录 1164 例 AE(1039 例患者的 1112 只眼,发生率为 6.0%,1:17 眼)。最常见的 AE 是后发性白内障(PCO;748 只眼,发生率为 4.0%)。所有 AE 中,有 171 例(151 例患者的 165 只眼,发生率为 0.9%,1:113 眼)被归类为严重、潜在威胁视力的事件。排除因 PCO 导致 CDVA 丧失的眼后,2 行以上 CDVA 丧失的发生率为 0.56%;其中大多数是由于黄斑原因所致。
在选择性屈光性晶状体置换术中,威胁视力的 AE 和显著的 CDVA 丧失发生率较低。除 PCO 外,该队列中视力丧失的最常见原因是术后黄斑问题。